US Government Officials have implored ten major pharmaceutical companies to give up information in the race to solve the 2007-2008 contaminated Chinese herparin incident.
Synteract says the use of non-validated data systems in clinical trials is a key driver for the ‘rescue study’ segment of the contract research sector.
Onco Therapies Limited (OTL), a division of Aglia, a wholly owned subsidiary of Strides Arcolab Limited, has been given the go ahead from Europe for its Oral Dosage Oncology facility.
US CRO Parexel says the pharmaceutical industry’s desire to access international markets is the key challenge facing regulatory experts in the contract research sector.
CRO Toxikon is expanding its efficacy and surgical research services (ESRS) unit in Bedford, Massachusetts to bolster its preclinical services offering for drug and medical device developers.
The glass packaging industry in Europe posted a 3.5 per cent year-on year production increase to 20.7m tonnes in 2010 as output partially recovered from its 2009 slump.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, PPD, Catalent, Celerion, Pharmanet and CIToxLAB.
Chiltern says that strategic partnering in the contract research sector enables CROs to plan for the longer term and is having a tangible impact on brining drugs to market.
Prosonix has secured funding to move its pipeline of proprietary mono and multi-component combination respiratory therapies through clinical development.
Almac has set up new depots for clinical trial materials in Asia-Pacific as part of a plan to build its presence in a one of the world’s fastest growing markets.
Sherpa Clinical Packaging says its new facility has passed an inspection by the California Food and Drug Branch (FDB) of the Department of Public Health.
DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.
in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics.
CRO Quintiles chose DIA 2011 to launch its new Infosario clinical trial data and information management system which, it says, will ‘bust’ the information silos that hamper the research process.
US CRO Celerion gained Brazilian National Health Surveillance Agency (Agência Nacional de Vigilancia Sanitaria ANVISA) approval for its bioanalysis labs in Lincoln, Nebraska and in Belfast, Northern Ireland.
Gerresheimer will expand its pharmaceutical packaging plant in the Czech Republic to meet growing demand for plastic systems and to further expand a key training hub.
The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.
US drug giant Pfizer will maintain a 350-strong research unit at its facility in Sandwich, Kent in the UK after revising its previous plan to find CROs to take over R&D operations.
PRA International says that the adoption of new industry standards is changing how the research sector approaches data and information management and is creating opportunities for the use of innovative technologies.
Contract manufacturing organisation (CMO) Neuland Laboratories will showcase its expanded capabilities for synthetic peptide manufacture at the 22nd American Peptide Symposium to be held in San Diego, US later this week.
Sponsors should bring together vendors before a trial begins and have them share information and experiences that will make the project successful, said a consultant at DIA.
CRO Clintec International has opened offices in China, Singapore and Thailand in a move designed to consolidate its presence in the Asia Pacific region.
A new firm joined the contract research sector this week with the launch of Neox Europe, an organisation combining a number of CROs operating across the continent that has global ambitions.
